openPR Logo
Press release

Opportunity Assessment in Transcatheter Aortic Valve Replacement (TAVR) Market by 2025 - Boston Scientific Corporation, Direct Flow medical, Inc., Edwards Lifesciences Corporation, HLT, Inc.

11-05-2018 10:36 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Transcatheter Aortic Valve Replacement (TAVR) Market

Transcatheter Aortic Valve Replacement (TAVR) Market

Transcatheter Aortic Valve Replacement (TAVR), known as transcatheter aortic valve implantation (TAVI) the surgical procedure for heart disease wherein transcatheter heart valve is used to replace the damaged as well as old heart valve. Transcatheter heart valve implantation is a minimally invasive process that helps in substituting the damaged heart valve with a prosthetic valve for treatment of mitral regurgitation and unembellished aortic stenosis. Transcatheter aortic valve replacement procedure that helps to diminish severe degenerative aortic stenosis and increases the survival rate of patients.

Request Sample Pages for more Professional and Technical insights @
http://bit.ly/2PIZBE0

Growth Factors: -

Transcatheter Aortic Valve Replacement (TAVR) Market is anticipated to reach USD 8,241.4 Million by 2025 according to a new study published by Polaris Market Research.

Transcatheter Aortic Valve Replacement (TAVR) Market is driven by factors such as growing number of the patient pool with cardiovascular ailments such as coronary artery diseases, heart failures, and hypertension. According to World Health Organization (WHO), the number of people suffering cardiovascular disorders will surge to 22.2 million by 2030 globally.

Moreover, rising implementation of minimally intrusive processes over traditional surgical open-heart procedures, reduction in hospital stays, low risk of infection, minimal blood loss is further propelling the market. Moreover, increase in occurrence of aortic stenosis disorders coupled with rise in elderly population, evolution in implementation rate of transcatheter aortic valve implantation procedure owing to high demand for minimally invasive procedures, an increase in medical and clinical indication of safety & efficacy and new products approvals are other factors propelling the Transcatheter Aortic Valve Replacement (TAVR) Market growth.

Some of the major key players operating in Transcatheter Aortic Valve Replacement (TAVR) Market are: -

• Boston Scientific Corporation
• Direct Flow medical Inc.
• Edwards Lifesciences Corporation
• HLT Inc.
• JenaValve Technology Inc.
• Medtronic plc
• Meril Life Sciences Pvt. Ltd.
• St. Jude Medical Inc.
• SYMETIS SA
• Transcatheter Technologies GmbH

For 'Queries' related to this research report, Make an Enquiry @
http://bit.ly/2PJmtTO

Segmentation: -

On the basis of surgical procedure, the Transcatheter Aortic Valve Replacement (TAVR) Market is categorized into Transfemoral (TF) Implantation, Transapical (TA) Implantation, and Transaortic Implantation. The global market by the surgical procedure is dominated by Transfemoral (TF) Implantation majorly due to growing focus on tentative products by key players which are estimated to boost the market growth of transcatheter valve replacement (TAVR) market globally. Moreover, Transfemoral implantation is the standardized as well as consistent TAVR procedure, in which an artificial valve is inserted through the femoral blood vessel with the minimally invasive procedure and negligible anesthesia. Thus, the transferomal (TF) implantation segment accounted for the highest market share in 2017 and is anticipated to preserve the governance during the forecast period.

Based on the end users, the Transcatheter Aortic Valve Replacement (TAVR) Market is further categorized into hospitals, ambulatory surgical centers, and cardiac catheterization laboratory. The Hospital segment is expected to show the highest market growth over the forecast period. Growing patient pool and rising demand for efficient and effective surgical process with shorter recovery time and reduced hospital stay are the key factors driving the market shares for hospitals in market.

Table of Content of Transcatheter Aortic Valve Replacement (TAVR) Market:

Chapter 1. Overview and Scope
Chapter 2. Market Summary
Chapter 3 Transcatheter Aortic Valve Replacement (TAVR) Market Size and Forecast
Chapter 4. Dynamics and Segmentation
Chapter 5. Detailed Insight on Key Company
Chapter 6. Research Methodology and Reference
Chapter 7. Competitive Landscape
TOC Continued…...!!!

About Us:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact Us:
Mr. Neel
Corporate Sales, USA
Polaris Market Research and Consulting
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Opportunity Assessment in Transcatheter Aortic Valve Replacement (TAVR) Market by 2025 - Boston Scientific Corporation, Direct Flow medical, Inc., Edwards Lifesciences Corporation, HLT, Inc. here

News-ID: 1351572 • Views:

More Releases from Polaris Market Research & Consulting

Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of 5.2%
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of …
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors. Market at a Glance In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. It
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 Billion by 2034, Growing at a CAGR of 7.5%
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 …
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 3.82 billion in 2024 and is expected to
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expanding at a CAGR of 6.8%
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin …
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billion
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2034, Growing at a CAGR of 7.44%
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 …
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 31.67 billion in 2024 and is expected to reach

All 5 Releases


More Releases for Transcatheter

Transcatheter Valve Market Future Prediction Report By 2032
The global transcatheter valve market was valued at approximately USD 9.7 billion in 2022 and is projected to reach around USD 31.54 billion by 2032, reflecting a compound annual growth rate (CAGR) of 14% during the forecast period from 2024 to 2032. Transcatheter Valve Market Overview The global transcatheter valve market is experiencing rapid growth, driven by the increasing prevalence of cardiovascular diseases and the rising adoption of minimally
Major Market Shift in Transcatheter Embolization And Occlusion Devices Industry: …
What Is the Forecasted Market Size and Growth Rate for the Transcatheter Embolization And Occlusion Devices Market? The market size of transcatheter embolization and occlusion devices has seen swift expansion in recent years. It is predicted to escalate from $4.76 billion in 2024 to $5.28 billion in 2025, with a compound annual growth rate (CAGR) of 10.9%. The surge during the historic era can be ascribed to the expansion in
Transcatheter Heart Valve Replacement Market Forecast Report By Type (Transcathe …
Global Transcatheter Heart Valve Replacement Market The global Transcatheter Heart Valve Replacement (THVR) market is poised for significant growth, with projections indicating an expansion from US$6.34 billion in 2023 to US$17.58 billion by 2032. This represents a robust compound annual growth rate (CAGR) of 11.99% from 2024 to 2032. The market's growth is primarily driven by an aging population, increasing prevalence of cardiovascular diseases, and advancements in minimally invasive procedures. Transcatheter Heart
Transcatheter Cardiac Pacemaker Market Size 2024 to 2031.
Market Overview and Report Coverage A Transcatheter Cardiac Pacemaker is a cutting-edge medical device used in the treatment of heart rhythm disorders by delivering electrical impulses to regulate the heartbeat. The market for these innovative devices is expected to experience significant growth in the coming years. The Transcatheter Cardiac Pacemaker Market is projected to grow at a CAGR of 12.60% during the forecasted period, driven by factors such as
Transcatheter Heart Valve Replacement Repair Market
The Transcatheter Heart Valve Replacement Repair Market is expected to grow on an unabashed note in the next decade. With a worldwide shortage of healthcare staff, the healthcare IT solutions comprising web-based staffing platforms are doing the rounds. The future scenario won't be any different. These platforms would show the gaps, i.e. actual dearth of healthcare personnel like nurse's doctors, technicians, lab workers, and clinicians, which would help the entire
Recent Study on Transcatheter Valve Market: 2019-2026 Global Industry Key Compan …
The Global Transcatheter Valve Market is high risk of complications from surgical aortic valve replacement is driving the growth of the market. However, high risk of blood vessel tearing yet remains major restraints to the market. Get Sample copy @ https://www.orianresearch.com/request-sample/1099645 Key players profiled in the report includes: Boston Scientific Corporation, Direct Flow medical, Edwards Lifesciences Corporation, HLT, JenaValve Technology, Medtronic plc, Meril Life Sciences Pvt. Ltd., St. Jude Medical, SYMETIS